Clinical Trial Update: Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing MUD SCT [Phase 2]

View source ↗

Summary

A Phase II trial evaluating busulfan and fludarabine as preparative conditioning therapy in adults with hematopoietic disorders undergoing matched-unrelated don…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Aplastic Anemia
• Chronic Myeloid Leukemia
• Multiple Myeloma
• Myelodysplastic Syndromes
• Myeloproliferative Neoplasms
• Non-hodgkin Lymphoma

Drugs mentioned

• BUSULFAN (Busulfan)
• Fludarabine (Fludarabine)

Snippet

Sponsor: University of California, San Francisco | Conditions: Chronic Myeloid Leukemia, Acute Myelogenous Leukemia | Phase 2 | Status: COMPLETED